Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

5MPN

Copy Product Info
😃Good
Catalog No. T40565Cas No. 47208-82-2
Alias 5-MPN

5MPN is an orally active and selective inhibitor of 6-phosphofructokinase-2-kinase (PFKFB4) that competitively inhibits the F6P binding site and inhibits the proliferation of myeloma cells, and can be used in the study of myeloproliferative neoplasms.

5MPN

5MPN

Copy Product Info
😃Good
Purity: 99.69%
Catalog No. T40565Alias 5-MPNCas No. 47208-82-2
5MPN is an orally active and selective inhibitor of 6-phosphofructokinase-2-kinase (PFKFB4) that competitively inhibits the F6P binding site and inhibits the proliferation of myeloma cells, and can be used in the study of myeloproliferative neoplasms.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$98-In Stock
5 mg$172-In Stock
10 mg$289-In Stock
25 mg$579-In Stock
50 mg$928-In Stock
100 mg$1,490-In Stock
200 mg$1,970-In Stock
1 mL x 10 mM (in DMSO)$188-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.69%
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
5MPN is an orally active and selective inhibitor of 6-phosphofructokinase-2-kinase (PFKFB4) that competitively inhibits the F6P binding site and inhibits the proliferation of myeloma cells, and can be used in the study of myeloproliferative neoplasms.
Targets&IC50
PFKFB4:8.6 μM (Ki)
In vitro
In H460 cells, 5MPN (0-30 μM; 24 hours) is able to inhibit the expression of PFKFB4[2].
In vivo
5MPN (120 mg/kg; p.o.) effectively inhibits the growth of Lewis lung carcinomas (LLC) in C57BL/6 mice and H460 human lung adenocarcinoma xenografts in athymic mice, without impacting body weight. A decline in Ki67-positive cells within LLC xenografts suggests 5MPN interferes with cell cycle progression in vivo[1].
Synonyms5-MPN
Chemical Properties
Molecular Weight305.33
FormulaC15H19N3O4
Cas No.47208-82-2
SmilesCOc1cccc2c(NCCCCCO[N+]([O-])=O)ccnc12
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (262.01 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (10.81 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.2751 mL16.3757 mL32.7514 mL163.7572 mL
5 mM0.6550 mL3.2751 mL6.5503 mL32.7514 mL
10 mM0.3275 mL1.6376 mL3.2751 mL16.3757 mL
20 mM0.1638 mL0.8188 mL1.6376 mL8.1879 mL
50 mM0.0655 mL0.3275 mL0.6550 mL3.2751 mL
100 mM0.0328 mL0.1638 mL0.3275 mL1.6376 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy 5MPN | purchase 5MPN | 5MPN cost | order 5MPN | 5MPN chemical structure | 5MPN in vivo | 5MPN in vitro | 5MPN formula | 5MPN molecular weight